Breaking News Can-Fite Biopharma Ltd (NYSE: CANF) Rallies on Positive News about Liver Cancer Treatment Can-Fite Biopharma Ltd (NYSE: CANF) has been gaining steadily for the last few days. At the time of writing, the stock is up by 31.12% to trade at $3.36. Its upside momentum is driven by positive sentiment after it announced Q3 results.